1. Home
  2. GDC vs CVKD Comparison

GDC vs CVKD Comparison

Compare GDC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • CVKD
  • Stock Information
  • Founded
  • GDC 2015
  • CVKD 2022
  • Country
  • GDC United States
  • CVKD United States
  • Employees
  • GDC N/A
  • CVKD N/A
  • Industry
  • GDC Steel/Iron Ore
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • GDC Industrials
  • CVKD Health Care
  • Exchange
  • GDC Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • GDC 29.0M
  • CVKD 29.5M
  • IPO Year
  • GDC N/A
  • CVKD 2023
  • Fundamental
  • Price
  • GDC $3.64
  • CVKD $13.06
  • Analyst Decision
  • GDC
  • CVKD Strong Buy
  • Analyst Count
  • GDC 0
  • CVKD 1
  • Target Price
  • GDC N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • GDC 168.2K
  • CVKD 33.5K
  • Earning Date
  • GDC 08-13-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • GDC N/A
  • CVKD N/A
  • EPS Growth
  • GDC N/A
  • CVKD N/A
  • EPS
  • GDC N/A
  • CVKD N/A
  • Revenue
  • GDC N/A
  • CVKD N/A
  • Revenue This Year
  • GDC N/A
  • CVKD N/A
  • Revenue Next Year
  • GDC N/A
  • CVKD N/A
  • P/E Ratio
  • GDC N/A
  • CVKD N/A
  • Revenue Growth
  • GDC N/A
  • CVKD N/A
  • 52 Week Low
  • GDC $1.03
  • CVKD $5.70
  • 52 Week High
  • GDC $12.18
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • GDC 62.52
  • CVKD 49.88
  • Support Level
  • GDC $2.32
  • CVKD $11.00
  • Resistance Level
  • GDC $3.76
  • CVKD $13.56
  • Average True Range (ATR)
  • GDC 0.33
  • CVKD 1.11
  • MACD
  • GDC 0.03
  • CVKD 0.23
  • Stochastic Oscillator
  • GDC 77.17
  • CVKD 80.67

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: